Home > Boards > US OTC > Medical - Drugs > Innovation Pharmaceuticals Inc. (IPIX)

I am European, in Europe no one has

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Michel Member Profile
 
Followed By 70
Posts 10,323
Boards Moderated 0
Alias Born 02/23/10
160x600 placeholder
The Emerging Growth Conference is Today.  Register Now. InvestorsHub NewsWire - 6/9/2021 7:00:00 AM
Patient enrollment reaches 90 percent in Innovation Pharmaceuticals' mid-stage COVID-19 trial Seeking Alpha - 5/27/2021 10:29:46 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/13/2021 8:01:45 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 5/3/2021 12:54:36 PM
Innovation gives update on mid-stage Brilacidin COVID-19 trial Seeking Alpha - 4/5/2021 8:03:34 AM
CLS Holdings, (OTCQB: CLSH) $1.49 million Net Revenue for Feb Highest in Company History InvestorsHub NewsWire - 3/9/2021 6:37:33 AM
Innovation updates on mid-stage Brilacidin COVID-19 trial Seeking Alpha - 3/5/2021 1:07:47 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/22/2021 11:20:39 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 2/17/2021 8:01:12 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/11/2021 4:47:49 PM
CLS Holdings, (OTCQB: CLSH) Record January NET Revenue of $1.48 Million Beating Target InvestorsHub NewsWire - 2/9/2021 6:48:48 AM
CLS Holdings, (OTCQB: CLSH) $17 million Sales, 60% Growth & 5 New Products InvestorsHub NewsWire - 2/2/2021 6:52:54 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/15/2021 12:36:13 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/22/2020 9:01:10 AM
Biotech Companies; Recent Milestones and Potential Upside InvestorsHub NewsWire - 12/22/2020 8:05:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 12/10/2020 6:03:50 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/16/2020 12:47:44 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/16/2020 9:01:35 AM
Epazz, Inc. (OTC Pink: EPAZ) Adds Vaccine Management as part of COVID Compliance Features InvestorsHub NewsWire - 11/10/2020 6:48:57 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/2/2020 12:00:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/15/2020 10:02:03 AM
Annual Report (10-k) Edgar (US Regulatory) - 9/14/2020 4:51:25 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/4/2020 9:32:58 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/4/2020 9:30:11 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/22/2020 10:01:06 AM
Michel   Friday, 05/07/21 01:55:25 AM
Re: Hugon post# 358256
Post # of 362678 
I am European, in Europe no one has heard of Brilacidin, it has never been on the cover of a newspaper, magazine or television.
Maybe Aplidin from Pharma Mar, approved Phase III.
Russia is not the European Union,
There we are doing the Phase II study almost completely
Nothing that can be approved in Russia will be used in Europe without prior approval from the European Medicines Agency and Russia is not an example of transparency
The European Medicines Agency has not approved the Sputnik vaccine because Russia does not provide the study data,

https://www.finanzas.com/ibex-35/phamamar-tendra-en-agosto-los-resultados-de-la-fase-iii-del-aplidin.html
https://www.economiadigital.es/galicia/politica/sanidad-da-por-hecha-la-aprobacion-del-aplidin-el-tratamiento-de-pharma-mar-contra-el-covid.html

I am Spanish, I know this company and I am very afraid that they will arrive before us wandering through Russia

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences